Publicerade artiklar helt/delvis vid Stockholm CF center/ Karolinska Universitetssjukhuset, Huddinge.
Backström-Eriksson L, Bergsten-Brucefors A, Hjelte L, Melin B, Sorjonen K. Associations between genetics, medical status, physical exercise and psychological wellbeing in adults with Cystic Fibrosis. BMJ Open Respiratory Research. Accepted.
Hochwälder J, Bergsten Brucefors, Hjelte L. Psychometric evaluation of the Swedish translation of the revised cystic fibrosis questionnaire in adults. Uppsala Journal of Medical Sciences. Accepted.
Pincikova T, Flodström-Tullberg M, Hjelte L. Cystic Fibrosis bronchial epithelial cells have impaired ability to activate vitamin D. Acta Paediatr. 2016 Feb 10. doi: 10.1111/apa.13361. [Epub ahead of print].
Rodriguez Hortal MC, Hjelte L, Nygren-Bonnier M. Non invasive ventilation as airway clearance technique in cystic fibrosis. Physiother Res Int. 2016 Feb 29. doi: 10.1002/pri.1667. [Epub ahead of print].
Wainwright CE, Elborn JS, Ramsey BW, Marigowda G, Huang X, Cipolli M, Colombo C, Davies JC, De Boeck K, Flume PA, Konstan MW, McColley SA, McCoy K, McKone EF, Munck A, Ratjen F, Rowe SM, Waltz D, Boyle MP; TRAFFIC Study Group; TRANSPORT Study Group. Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. N Engl J Med. 2015 Jul 16;373(3):220-31. doi: 10.1056/NEJMoa1409547. Epub 2015 May 17.
Backström L, Sorjonen K, Hjelte L, Melin B. Anxiety and depression among adult CF-patients in comparison with the general population, in Sweden and three other European countries. BMC Pulm Med. 2015 Oct 14;15:121. doi: 10.1186/s12890-015-0117-9.
Hussain R, Shahror R, Karpati F and Roomans GM. Glucocorticoids can affect Pseudomonas aeruginosa (ATCC 27853) internalization and intracellular calcium concentration in cystic fibrosis bronchial epithelial cells. Experimental Lung Research 2015, 41:7, 383-392.
Qvist T, Gilljam M, Jönsson B, Taylor-Robinson D, Jensen-Fangel S, Wang M, Svahn A, Kötz K, Hansson L, Hollsing A, Hansen CR, Finstad PL, Pressler T, Høiby N, Katzenstein TL; Scandinavian Cystic Fibrosis Study Consortium (SCFSC).Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia.J Cyst Fibros. 2015 Jan;14(1):46-52. doi: 10.1016/j.jcf.2014.08.002. Epub 2014 Aug 30.
Rodriguez MC, Hjelte L. Time point to perform lung function tests evaluating the effects of an airway clearance therapy session in cystic fibrosis. Respir Care. 2014 Oct;59(10):1537-41. doi: 10.4187/respcare.02823. Epub 2014 May 20.
Kerem E, Konstan MW, De Boeck K, Accurso FJ, Sermet-Gaudelus I, Wilschanski M, Elborn JS, Melotti P, Bronsveld I, Fajac I, Malfroot A, Rosenbluth DB, Walker PA, McColley SA, Knoop C, Quattrucci S, Rietschel E, Zeitlin PL, Barth J, Elfring GL, Welch EM, Branstrom A, Spiegel RJ, Peltz SW, Ajayi T, Rowe SM. Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial. Lancet Respir Med. 2014 Jul;2(7):539-47. doi: 10.1016/S2213-2600(14)70100-6. Epub 2014 May 15.
Naehrlich L, Ballmann M, Davies J, Derichs N, Gonska T, Hjelte L, van Konigsbruggen-Rietschel S, Leal T, Melotti P, Middleton P, Tümmler B, Vermeulen F, Wilschanski M; on behalf of the ECFS Diagnostic Network Working Group. Nasal potential difference measurements in diagnosis of cystic fibrosis: An international survey. J Cyst Fibros. 2014 Jan;13(1):24-8. doi: 10.1016/j.jcf.2013.08.006. Epub 2013 Sep 7.
Döring G, Flume P, Heijerman H, Elborn JS; Consensus Study Group. Treatment of lung infection in patients with cystic fibrosis: Current and future strategies. J Cyst Fibros. 2012 Dec;11(6):461-79. doi: 10.1016/j.jcf.2012.10.004. Epub 2012 Nov 6.
Moen IE, Nilsson K, Andersson A, Fagerland MW, Fluge G, Hollsing A, Gilljam M, Mared L, Pressler T, Santi H, Storrøsten OT, Hjelte L. Dietary intake and nutritional status in a Scandinavian adult cystic fibrosis-population compared with recommendations. Food Nutr Res. 2011;55. doi: 10.3402/fnr.v55i0.7561. Epub 2011 Nov 17.
Pincikova T, Nilsson K, Moen I, Fluge G, Hollsing A, Knudsen P, Lindblad A, Mared L, Pressler T, Hjelte L. Vitamin D deficiency as a risk factor for CF-related diabetes in the Scandinavian Cystic Fibrosis Nutritional Study. Diabetologia. 2011 Dec;54(12):3007-15. Epub 2011 Sep 7.
De Boeck K, Derichs N, Fajac I, de Jonge HR, Bronsveld I, Sermet I, Vermeulen F, Sheppard DN, Cuppens H, Hug M, Melotti P, Middleton PG, Wilschanski M; ECFS Diagnostic Network Working Group; EuroCareCF WP3 Group on CF diagnosis. New clinical diagnostic procedures for cystic fibrosis in Europe. J Cyst Fibros. 2011 Jun;10 Suppl 2:S53-66. Review.
Bilton D, Canny G, Conway S,Dumcius S, Hjelte L, Proesmans M, Tümmler B, Vavrova V, De Boeck K. Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials. J Cyst Fibros. 2011 Jun;10 Suppl 2:S79-81.
Pressler T, Bohmova C, Convay S, Dumicius S, Hjelte L, Hoiby N, Kollberg H, Tummler B, Vavrova V. Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group report. J Cyst Fibros. 2011 Jun;10 Suppl 2:S75-8.
Geborek A, Hjelte L.Correlation between Genotype and Pulmonary Phenotype in Cystic Fibrosis patients with severe CFTR mutations. J Cystic Fibrosis. 2011 May; 10(3):187-92.
de Monestrol I, Klint Å, Sparén P, Hjelte L. Age at diagnosis and disease progression of cystic fibrosis in an area without newborns screening. Paediatr Perinat Epidemiol, 2011 May;25(3) : 298-305.
de Monestrol I, Sjöberg B, Bergsten Brucefors A, Hjelte L. Parental Support for Newborn Screening for Cystic Fibrosis: Acta Paediatrica 2010; 100:209-215.
Zhanna Servetnyk, Su Jiang, Lena Hjelte , Benjamin Gaston, Godfried M. Roomans and Anca Dragomir. The effect of S-nitrosoglutathione and L-cysteine on chloride efflux from CF airway epithelial cells. Exp Mol Pathol. 2011 Feb;90(1):79-83. Epub 2010 Oct 19.
Bergsten Brucefors A, Hjelte L, Hochwälder L. Mental health and sense of coherence among Swedish adults with cystic fibrosis. Scand J Caring Sciences Scand J Caring Sci. 2010 Nov 19. doi: 10.1111/j.1471-6712.2010.00840.x. [Epub ahead of print].
Pincikova T, Nilsson K, Moen IE, Karpati F, Ericsson-Hollsing A, Fluge G, Knudsen PK, Lindblad A, Mared L, Pressler T, Hjelte L. Vitamin D as a determinant of serum total IgG level in Scandinavian cystic fibrosis patients. Eur Eur J Clin Nutr. 2011 Jan;65(1):102-9. Epub 2010 Sep 22.
Olesen HV, Pressler T, Hjelte L, Mared L, Lindblad A, Knudsen PK, Lærum BN, Johannesson M. Gender differences in the Scandinavian cystic fibrosis population. Pediatric Pulmonology. 2010 Oct;45(10):959-65.
Heijerman H, Westerman E, Conway S, Touw C, Döring G; consensus working group. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus. J Cyst Fibros. 2009 Sep;8(5):295-315. Epub 2009 Jun 25.
Goubau C, Castellani C,Wilschanski M, Skalická V, Lebecque P, Southern K, Sermet I, Munck A, Derichs D, Middleton P, Hjelte L, Padoan R, Vasar M, De Boeck K. Classic versus non-classic cystic fibrosis: evaluation of patient categories according to a diagnostic algorithm. Thorax. 2009 Aug;64(8):683-91. Epub 2009 Mar 23.
Azad Abul Kalam1, Rauh R, Jaspers M, Korbmacher J, Stanke F, Nuytten H, Radojkovic D, Tümmler B, De Boeck C, Dupont L, Macek M Jr, Zemkova D, Vavrova V, Hjelte L, de Monestrol I, Lagerstedt K, Claustres M, des Georges M, Claude F, Fichou Y, Girodon E, Stuhrmann M, Schwartz M, Pressler T, Castellani C, Schwarz M, Cassiman JJ, Korbmacher C, Cuppens H. Mutations in the amiloride-sensitive epithelial sodium channel in patients with cystic fibrosis-like disease. Human Mutat 2009 Jul;30(7):1093-103.
Islam S, Oh H, Jalal S, Karpati F, Ciofu O, Høiby N, Wretlind B. Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Clinical Microbiology and Infection 15:1 (2009) 60-66.
Fluge G, Olesen HV, Gilljam M, Meyer P, Tanja H, Storrösten OT, Karpati F, Hjelte L. Co-morbidity of cystic fibrosis and coeliac disease in Scandinavian cystic fibrosis patients. J Cyst Fibr 8 (2009): 198-202.
Knudsen PK, Olesen HV, Høiby N, Johannesson M, Karpati F, Laerum BN, Meyer P, Pressler T, Lindblad Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden. A. Journal of Cystic Fibrosis 2009, 8(2):135-142.
Pressler P, Karpati F, Granström M, Knudsen PK, Lindblad A, Hjelte L, Olesen HV, Høiby H. Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by two different ELISA methods. J Cyst Fibros. 2009 Jan;8(1):37-42. Epub 2008 Oct 5.
Ohlsson L, Hjelte L, Hühn M, Scholte BJ, Wilke M, Flodström-Tullberg M, Nilsson Å. Expression of intestinal and lung alkaline sphingomyelinase and neutral ceramidase in cystic fibrosis F508del transgenic mice". J Pediatr Gastroenterol Nutr. 2008 Nov;47(5):547-54.
Nydert P, Dragomir A, Hjelte L. Chitosan as a carrier for non viral gene transfer in a cystic fibrosis cell line. Biotechnol Appl Biochem. 2008 Dec;51(Pt 4):153-7.
Dahlin M, Hjelte L, Nilsson S, Åmark P. Plasma phospholipids fatty acids are influenced by a ketogenic diet enriched with n-3 fatty acids in children with epilepsy. Epilepsy Res 2007;73:199-207.
Gustafsson B, Karpati F, Söderhäll S, Sander B, Nordenstrom A, Nordvall M, von Döbeln U. Myelodysplastic features and symptoms mimicking cystic fibrosis in a child with an intracellular vitamin B 12 deficiency. Letter to the Editor. Pediatr Blood Cancer. 2007, 49(7):1054-5.
Servetnyk Z, Krjukova J, Gaston B, Hjelte L, Roomans G M, Dragomir A. Activation of ∆F508 CFTR in CF airway epithelial cell lines and CF nasal epithelial cells by S-nitrosoglutathione. Respir Res. 2006;7:124
Lindström M, Falk R, Hjelte L, Philipson K, Svartengren M. Long-term clearance from small airways in subjects with ciliary dysfunction.Respir Res. 2006 May 20;7:79.
De Boeck K, Wilschanski M, Castellani C, Taylor C, Cuppens H, Dodge J, Sinaasappel M. For the European Diagnostic Working Group. (L Hjelte m fl). Cystic fibrosis: terminology and diagnostic algorithms. Thorax. 2006;61:627-35. Epub 2005 Dec 29
Kerem E., Conway S., Elborn S., Heijerman H. For the Consensus Committee (L Hjelte m fl). Standards of care for patients with cystic fibrosis: a European consensus. J Cystic Fibrosis 2005;4:7-26.
Lindström M., Camner P., Falk R., Hjelte L., Philipsson K., Svartengren M. Long term clearance from small ciliated airways in patients with Cystic Fibrosis. European Respiratory Journal 2005-25:317-23.
Karpati F, Meurling L, Wretlind B, Hjelte L. Interleukin-8 in sputum from cystic fibrosis patients during ibuprofen treatment. (Chapter IX, in: Progress in Cystic Fibrosis Research, Nova Science Publishers, Hauppauge, N.Y., U.S.A.) 2005. 171-183.
Dragomir A, Björstedt J, Hjelte L, Roomans GM. Curcumin does not stimulate cAMP-mediated chloride transport in cystic fibrosis airway epithelial cells. Biochemical and Biophysical Research Communication. 2004;17:447-51.
Munkonge F, Alton E, Andersson C, Davidson H, Dragomir A, Edelman A, Farley R, Hjelte L, Mclachlan G, Sern M, Roomans G. Measurement of halide efflux from cultured and primary airway epithelial cells using fluorescence indicators. J Cystic Fibrosis. 2004;3:171-176.
Dragomir A, Hjelte L, Roomans G. Heparin can improve the viability of transfected cystic fibrosis cell lines in vitro. Life Sciences 2004;75:2203-2216.
Kolak M, Karpati F, Nonstein H-J, Jonasson J. Molecular typing of teh bacterial flora in sputum of cystic fibrosis patients. International Journal of Medical Microbiology 2003;293:309-317.
Forslöw U, Geborek A, Hjelte L, Petrini B, Heurlin N. Early chemotherapy for non-tuberculous mycobacterial infections in cystic fibrosis patients. Acta Paediatr 2003;92:910-915.
Hjelte L. Cystisk Fibros. In Barnmedicin. 2:a uppl. Edited by Lindberg T, Lagercrantz H. Studentlitteratur, Lund 2003.
Andersson C, Dragomir A, Hjelte L, Roomans GM. Cystic fibrosis transmembrane regulator activity in nasal epithelial cells from cystic fibrosis patients with different phenotypes. Clin Sci 2002;103:417-24.
Lagerstrand L, Ingemansson M, Bergström S-B, Lidberg K, Gustafsson P, Hedlin G och Hjelte L. Forcerad expiration bra sätt att mäta lungfunktionen hos späda och små barn. Läkartidningen 2002; 39:3818-3825.
Schaedel C, de Monestrol I, Hjelte L, Johannesson M, Kornfält R, Lindblad A, Strandvik B, Holmberg L. Predictors for deterioration of lung function in cystic fibrosis. Ped Pulmonol 2002;33:483-491.
Henriksson G, Westrin KM, Karpati F, Wikström A-C, Stierna P, Hjelte L. Nasal Polyps in Cystic Fibrosis . Clinical Endoscopic Study With Nasal Lavage Fluid Analysis. Chest 2002;121:40-47.
Karpati F, Giedraitis V, Thore M, Lindman R, Monstein H_J, Hjelte L, Jonasson J. Arbitrarily Primed PCR and Sequencing of 16rDNA for Epidemiological typing and Species Identification of Burkholderia cepacia Ixsolates from Swedish Patients with Cystic Fibrosis Reveal Genetic Heterogeneity. APMIS 2001;109:1389-400.
Dragomir A, Andersson C, Hjelte L, Roomans GM. Assessment of CFTR function in nasal epithelial cells by X-ray microanalysis. J Microsc 2001;203:277-284
Karpati F, Hjelte L, Wretlind B. TNF-alfa, IL-6 and IL-8 in consecutive sputum samples from cystic fibrosis patients during antibiotic treatment. Scand J Infect Dis 2000;32:75-79
Jakobsson, B-M, Hjelte L, Nyström B. Low bacterial contamination of mist tents. J Hosp Infect. 2000;44:37-41.
Hjelte L. Cystisk Fibros. MikroNytt. Redaktör Bengt Gästrin. 1999;4:3-5.
Schaedel C, Hjelte L, de Monestrol I, Johannesson M, Kollberg H, Kornfält R, Holmberg L. Three common CFTR mutations should be included in a neonatal screening programme for cystic fibrosis in Sweden. Clin Genet 1999;56:318-22.
Lagerstrand L, Jorulf H, Hjelte L. Pulmonary gas exchange in cystic fibrosis: Basal status and the effect of iv antibiotics and inhaled amiloride. Eur Resp J 1999;14:686-92.
Hjelte L. Cystisk Fibros. In Barnmedicin. Edited by Lindberg T, Lagercrantz H. Studentlitteratur, Lund 1999.
Johannesson M, Landgren B-M, Csemiczky G, Hjelte L, Gottlieb C. Female patients with cystic fibrosis suffer from reproductive endocrinological disorders despite good clinical status. Hum Reprod 1998;13:2092-2097.
Johannesson M, Carlson M, Bergsten Brucefors A, Hjelte L. Cystic fibrosis through a female perspective: puberty and motherhood. Patient Education and Counseling. 1998;34:115-123.
Johannesson M, Sandberg-Nordquist A-C, Bogdanovic N, Hjelte L, Schalling M. Polymorphic expression of Multidrug Resistance mRNA in lungprenchyma of nonpregnant and pregnant rats: a comparison to Cystic Fibrosis mRNA expression. Biochemical and Biophysical Researach Communication 1997;239:606-611.
Jakobsson B-M, Önnered A-B, Hjelte L, Nyström B. Low bacterial contamination of nebulizers in home treatment of cystic fibrosis. J Hosp Infect. 1997;56:219-227.
Johannesson M, Bogdanovic N, Sandberg-Nordqvist A-C, Hjelte L, Schalling M. Cystic Fibrosis mRNA expression in rat brain: cerebral cortex and medial preoptic area. NeuroReport 1997;8:535-539.
Johannesson M, Gottlieb C, Hjelte L. Delayed puberty in females with CF despite good nutritional status. Pediatrics 1997;99:29-34.
Strandvik B, Hjelte L, Malmborg A-S. Cystic Fibrosis Pulmonary Infection: The Swedish Experience. In:Cystic Fibrosis Pulmonary Infections: Lessons from Around the World. Respiratory Pharmacology and Pharmacotherapy. Edited by A Bauernfeind, MI Marks, B Strandvik. Basel, Boston, Berlin: Birkhäuser Verlag 1996.
Karpati F, Jonasson J. Polymerase chain reaction for the detection of Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia in sputum of patients with cystic fibrosis. Molecular and Cellular Probes (1996) 10:397-403.
Nilsson Å, Hjelte L, Strandvik B. Metabolism of orally fed 3H eicosapentaenoic and 14C arachidonic acid in essential fatty acid deficient rats. Scand J Clin Lab Invest. 1996;56:219-227.
Lindblad A, Strandvik B, Hjelte L. Incidence of liver disease in patients with cystic fibosis and meconium ileus. Editorial correspondence. J Pediatr 1995;126:155-6.
Dahl N, Grandell U, Martinsson T, Allen M, Johansson L, Stolpe L, Gyllensten U, Hjelte L, Kollberg H, Strandvik B, Wahlström J, Anvret M. Frequency of four cystic fibrosis mutations in a Swedish population. Acta Paediatr Scand 1993;82:609.
Karpati F, Malmborg A-S, Alfredsson H, Hjelte L, Strandvik B. Bacterial colonisation with Xanthomonas malthophilia - a retrospective study in a cystic fibrosis patient population. Infection 1994;22:258-263.
Freyschuss U, Hjelte L, Johannesson M, Nowak J, Sylvén C. Signal variance electrocardiogram: a test for early detection of myocardial involvement in cystic fibrosis? Clin Sci 1994;87:103-107.
Strandvik B, Hjelte L. Nephrolithiasis in cystic fibrosis. Acta Paediatr 1993;82:306-7.
Dahl N, Grandell U, Martinsson T, Allen M, Johansson L, Stolpe L, Gyllensten U, Hjelte L, Kollberg H, Strandvik B, Wahlström J, Anvret M. Frequency of four cystic fibrosis mutations in a Swedish population. Acta Paediatr Scand 1993;82:609.
Hjelte L, Malmborg A-S, Strandvik B. Home intravenous antibiotic treatment in cystic fibrosis. Acta Paediatr Scand 1992;81:340-344.
Christensson BA, Nilsson-Ehle I, Ljungberg B, Lindblad A, Malmborg A-S, Hjelte L, Strandvik B. Increased oral bio-availibility to ciprofloxacin in cystic fibrosis patients. Antimicrob Agents Chemother 1992;36:2512-2517.
Nilsson Å, Hjelte L, Strandvik B. Incorporation of dietary 3H eicosapentaenoic acid and 14C arachidonic acid into tisssue lipids during absorption of a fish oil emulsion. J Lipid Res 1992;33:1295-1305.
Obinata K, Carlström K, Hjelte L, Strandvik B. The effect of esssential fatty acid deficiency on hepatic bile salt sulphotransferase in rats. J Steroid Biochem Molec Biol 1992;42:625-626.
Stenvinkel T, Hjelte L, Alvan G, Hedman A, Hultman E, Strandvik B. Decreased renal clearance of sodium in cystic fibrosis. Acta Paediatr Scand 1991;80:194-198.
Nilsson Å, Hjelte L, Nilsson-Ehle P, Strandvik B. Adaptive regulation of lipoprotein lipase and salt resistant lipase activities in essential fatty acid eficient rats. Metabolism 1990;39:1305-1308.
Hjelte L, Ahrén B, Andrén-Sandberg Å, Böttcher G, Strandvik B. Pancreatic function in the essential fatty acid deficient rats. Metabolism 1990;39:871-875.
Hjelte L, Larsson M, Alvestrand A, Malmborg A-S, Strandvik B. Renal function in rats with essential fatty acid deficiency. Clin Sci 1990;79:299-305.
Hjelte L, Nilsson Å, Strandvik B. Metabolism of 3H-20:4 and 14C-18:2 labelled chylomicrons in essential fatty acid deficient rats. Biochim Biophys Acta 1990;1044:101-110.
Hjelte L, Melin T, Nilsson Å, Strandvik B. Absorption and metabolism of 3H-arachidonic acid and 14C-linoleic acid in essential fatty acid deficient rats. Am J Physiol 1990;259:G116-G124.
Hjelte L, Strandvik B, Muller RM, Sigström S, Roomans MG. Essential fatty acid deficient rats in the study of cystic fibrosis: an X-ray microanalytical and ultrastructural study. J Submicroscopic Cytol Pathol 1990;22:409-414.
Hjelte L. Essential fatty acid deficiency in relation to the symptomatology of cystic fibrosis. Biochemical, morphological and physiological studies in the growing rat. Thesis, 1990.
Hjelte L, Petrini B, Källenius G, Strandvik B. Mycobacteria in cystic fibrosis. Thorax 1990;45:397-400.
Strandvik B, Hjelte L, Lindblad A, Ljungberg B, Malmborg A-S, Nilsson-Ehle I. Comparison of efficacy and tolerance of intravenously and orally administered ciprofloxacin in cystic fibrosis patients with acute exacerbations of lunginfection. Scand J Inf Dis 1989;Suppl 60:80-88.
Hjelte L, Malmborg A-S, Strandvik B. Serum and sputum concentrations of netilmicin in combination with acylureidopenicillin and cephalosporins in clinical treatment of pulmonary exacerbations in cystic fibrosis. J Antimicrob Chemother 1989;23:885-890.
Hjelte L, Widén B, Malmborg A-S, Freyschuss U, Strandvik B. Intravenös antibiotikabehandling i hemmet vid cystisk fibros. Läkartidningen 1988;18:1614-161.
Strandvik B, Hjelte L, Malmborg A-S, Widén B. Home intravenous antibiotic treatment in cystic fibrosis. Scand J Gastroenterol 1988,23(suppl 143):119-121.
Strandvik B, Hjelte L, Gabrielsson N, Glaumann H: Sclerosing cholangitis in cystic fibrosis. Scand J Gastroenterol 1988;23(suppl 143):121-124.
Alvan G, Beerman B, Hjelte L, Lindholm A, Strandvik B. Increased nonrenal and increased diuretic efficiency of furosemide in cystic fibrosis. Clin Pharm 1988;44:436-441
Doktorsavhandlingar helt/delvis utgångna från CF-centret:
Hussain R Cell Responses in Infected and Cystic Fibrosis Respiratory Epithelium. Thesis. 2014. Huvudhandledare: Roomans, G. Bihandledare: Karpati F
Terezia Pincikova, thesis defense 2014. Vitamin D insufficiency in cystic fibrosis: Prevalence, Consequences and Intervention.
Gert Henriksson, thesis defense 2004. Clinical immunological and olfactory aspects of sinusitis and nasal polyposis - with special reference to patients with cystic fibrosis.
Maria Lindström, 2004, Particles in small airways: mechanisms for deposition and clearance & Pharmacokinetic assessment of delivered dose to the lung.
Ferenc Karpati, 2001, Bacterial colonisation and infection of the lower airways in cystic fibrosis. A microbiological and clinical study,(thesis), Stockholm.
Anders Lindblad, 1998, Liver disease in Cystic Fibrosis.
Marie Johannesson, 1998, Aspects on Puberty and Fertility among Females with Cystic Fibrosis - a multidisciplinary study on humans and rats.
Lena Hjelte, 1990, Essential Fatty Acid Deficiency in relation to the symptomatology of Cystic Fibrosis - Biochemical, Morphological and Physiological Studies in the Growing Rat.
Annika Hollsing, 1987, Serological Markers of Pulmonary Infection in Patients with Cystic fibrosis.
Hans Gilljam, 1987, Studies of the Large Airways in Adult Cystic Fibrosis.
